Dietary supplementation of genistein alleviates liver inflammation and fibrosis mediated by a methionine-choline-deficient diet in db / db mice

Journal of Agricultural and Food Chemistry

Volumn 63, Issue 17, 2015, Pages 4305-4311

  Yoo, Na Young ^a   Jeon, Sookyoung ^a   Nam, Yerim ^a   Park, Youn Jin ^a   Won, Sae Bom ^a   Kwon, Young Hye ^a  

^a Seoul National University   (South Korea)

Author keywords

db db mouse; fibrosis; genistein; methionine choline deficient diet; nonalcoholic steatohepatitis

Indexed keywords

AMINO ACIDS; CELL MEMBRANES; DIETARY SUPPLEMENTS; GENE EXPRESSION; MAMMALS; NUTRITION; OXIDATIVE STRESS; PATHOLOGY;

DB / DB MOUSE; DIETARY SUPPLEMENTATION; ENDOPLASMIC RETICULUM STRESS; FIBROSIS; GENISTEIN; LIPID PEROXIDATION; NON-ALCOHOLIC FATTY LIVER DISEASE; NON-ALCOHOLIC STEATOHEPATITIS;

FLAVONOIDS;

MUS;

CHOLINE; GENISTEIN; METHIONINE;

ADVERSE EFFECTS; ANALYSIS; ANIMAL; C57BL MOUSE; DEFICIENCY; DIET; DIET SUPPLEMENTATION; DISEASE MODEL; DRUG EFFECTS; HUMAN; IMMUNOLOGY; LIVER; LIVER CIRRHOSIS; MALE; METABOLISM; MOUSE; OXIDATIVE STRESS;

ANIMALS; CHOLINE; DIET; DIETARY SUPPLEMENTS; DISEASE MODELS, ANIMAL; GENISTEIN; HUMANS; LIVER; LIVER CIRRHOSIS; MALE; METHIONINE; MICE; MICE, INBRED C57BL; OXIDATIVE STRESS;

EID: 84928911576     PISSN: 00218561     EISSN: 15205118     Source Type: Journal    
DOI: 10.1021/acs.jafc.5b00398     Document Type: Article

References (46)

1. Anderson, N.; Borlak, J. Molecular mechanisms and therapeutic targets in steatosis and steatohepatitis Pharmacol Rev. 2008, 60, 311-57 10.1124/pr.108.00001
2. Lazo, M.; Clark, J. M. The epidemiology of nonalcoholic fatty liver disease: a global perspective Semin. Liver Dis. 2008, 28, 339-50 10.1055/s-0028-1091978
3. Day, C. P.; James, O. F. Steatohepatitis: a tale of two hits? Gastroenterology 1998, 114, 842-5 10.1016/S0016-5085(98)70599-2
4. Larter, C. Z.; Yeh, M. M. Animal models of NASH: getting both pathology and metabolic context right J. Gastroenterol. Hepatol. 2008, 23, 1635-48 10.1111/j.1440-1746.2008.05543.x
5. Varela-Rey, M.; Embade, N.; Ariz, U.; Lu, S. C.; Mato, J. M.; Martinez-Chantar, M. L. Non-alcoholic steatohepatitis and animal models: understanding the human disease Int. J. Biochem. Cell Biol. 2009, 41, 969-76 10.1016/j.biocel.2008.10.027
6. Leclercq, I. A.; Farrell, G. C.; Field, J.; Bell, D. R.; Gonzalez, F. J.; Robertson, G. R. CYP2E1 and CYP4A as microsomal catalysts of lipid peroxides in murine nonalcoholic steatohepatitis J. Clin. Invest. 2000, 105, 1067-75 10.1172/JCI8814
7. Gao, D.; Wei, C.; Chen, L.; Huang, J.; Yang, S.; Diehl, A. M. Oxidative DNA damage and DNA repair enzyme expression are inversely related in murine models of fatty liver disease Am. J. Physiol Gastrointest Liver Physiol 2004, 287, G1070-7 10.1152/ajpgi.00228.2004
8. Sahai, A.; Malladi, P.; Pan, X.; Paul, R.; Melin-Aldana, H.; Green, R. M.; Whitington, P. F. Obese and diabetic db/db mice develop marked liver fibrosis in a model of nonalcoholic steatohepatitis: role of short-form leptin receptors and osteopontin Am. J. Physiol Gastrointest Liver Physiol 2004, 287, G1035-43 10.1152/ajpgi.00199.2004
9. Hashimoto, E.; Tokushige, K. Prevalence, gender, ethnic variations, and prognosis of NASH J. Gastroenterol. 2011, 46 (Suppl 1) 63-9 10.1007/s00535-010-0311-8
10. Jones, M. E.; Thorburn, A. W.; Britt, K. L.; Hewitt, K. N.; Wreford, N. G.; Proietto, J.; Oz, O. K.; Leury, B. J.; Robertson, K. M.; Yao, S.; Simpson, E. R. Aromatase-deficient (ArKO) mice have a phenotype of increased adiposity Proc. Natl. Acad. Sci. U. S. A. 2000, 97, 12735-40 10.1073/pnas.97.23.12735
11. Helisten, H.; Hockerstedt, A.; Wahala, K.; Tiitinen, A.; Adlercreutz, H.; Jauhiainen, M.; Tikkanen, M. J. Accumulation of high-density lipoprotein-derived estradiol-17beta fatty acid esters in low-density lipoprotein particles J. Clin. Endocrinol. Metab. 2001, 86, 1294-300 10.1210/jcem.86.3.7292
12. Uzui, H.; Sinha, S. K.; Rajavashisth, T. B. 17beta-estradiol inhibits oxidized low-density lipoprotein-induced increase in matrix metalloproteinase-9 expression in human macrophages J. Investig. Med. 2011, 59, 1104-1108
13. Itagaki, T.; Shimizu, I.; Cheng, X.; Yuan, Y.; Oshio, A.; Tamaki, K.; Fukuno, H.; Honda, H.; Okamura, Y.; Ito, S. Opposing effects of oestradiol and progesterone on intracellular pathways and activation processes in the oxidative stress induced activation of cultured rat hepatic stellate cells Gut 2005, 54, 1782-9 10.1136/gut.2004.053728
14. Omoni, A. O.; Aluko, R. E. Soybean foods and their benefits: potential mechanisms of action Nutr. Rev. 2005, 63, 272-83 10.1111/j.1753-4887.2005.tb00141.x
15. Messina, M.; Messina, V. The role of soy in vegetarian diets Nutrients 2010, 2, 855-88 10.3390/nu2080855
16. Fang, N.; Yu, S.; Badger, T. M. Comprehensive phytochemical profile of soy protein isolate J. Agric. Food Chem. 2004, 52, 4012-20 10.1021/jf049842y
17. Nagaraju, G. P.; Zafar, S. F.; El-Rayes, B. F. Pleiotropic effects of genistein in metabolic, inflammatory, and malignant diseases Nutr. Rev. 2013, 71, 562-72 10.1111/nure.12044
18. Jeon, S.; Park, Y. J.; Kwon, Y. H. Genistein alleviates the development of nonalcoholic steatohepatitis in ApoE(-/-) mice fed a high-fat diet Mol. Nutr. Food Res. 2014, 58, 830-41 10.1002/mnfr.201300112
19. Ji, G.; Yang, Q.; Hao, J.; Guo, L.; Chen, X.; Hu, J.; Leng, L.; Jiang, Z. Anti-inflammatory effect of genistein on non-alcoholic steatohepatitis rats induced by high fat diet and its potential mechanisms Int. Immunopharmacol. 2011, 11, 762-8 10.1016/j.intimp.2011.01.036
20. Al-Nakkash, L.; Clarke, L. L.; Rottinghaus, G. E.; Chen, Y. J.; Cooper, K.; Rubin, L. J. Dietary genistein stimulates anion secretion across female murine intestine J. Nutr. 2006, 136, 2785-2790
21. Ju, Y. H.; Allred, C. D.; Allred, K. F.; Karko, K. L.; Doerge, D. R.; Helferich, W. G. Physiological concentrations of dietary genistein dose-dependently stimulate growth of estrogen-dependent human breast cancer (MCF-7) tumors implanted in athymic nude mice J. Nutr. 2001, 131, 2957-2962
22. Folch, J.; Lees, M.; Stanley, G. H. S. A simple method for the isolation and purification of total lipids from animal tissues J. Biol. Chem. 1957, 226, 497-509
23. Ohkawa, H.; Ohishi, N.; Yagi, K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction Anal. Biochem. 1979, 95, 351-8 10.1016/0003-2697(79)90738-3
24. Jung, G. Y.; Won, S. B.; Kim, J.; Jeon, S.; Han, A.; Kwon, Y. H. Betaine alleviates hypertriglycemia and tau hyperphosphorylation in db/db mice Toxicol. Res. 2013, 29, 7-14 10.5487/TR.2013.29.1.007
25. Yamaguchi, K.; Yang, L.; McCall, S.; Huang, J.; Yu, X. X.; Pandey, S. K.; Bhanot, S.; Monia, B. P.; Li, Y. X.; Diehl, A. M. Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis Hepatology 2007, 45, 1366-74 10.1002/hep.21655
26. Kaufman, R. J. Orchestrating the unfolded protein response in health and disease J. Clin. Invest. 2002, 110, 1389-98 10.1172/JCI16886
27. Tomita, K.; Oike, Y.; Teratani, T.; Taguchi, T.; Noguchi, M.; Suzuki, T.; Mizutani, A.; Yokoyama, H.; Irie, R.; Sumimoto, H.; Takayanagi, A.; Miyashita, K.; Akao, M.; Tabata, M.; Tamiya, G.; Ohkura, T.; Hibi, T. Hepatic AdipoR2 signaling plays a protective role against progression of nonalcoholic steatohepatitis in mice Hepatology 2008, 48, 458-73 10.1002/hep.22365
28. Larter, C. Z.; Yeh, M. M.; Williams, J.; Bell-Anderson, K. S.; Farrell, G. C. MCD-induced steatohepatitis is associated with hepatic adiponectin resistance and adipogenic transformation of hepatocytes J. Hepatol. 2008, 49, 407-16 10.1016/j.jhep.2008.03.026
29. Schattenberg, J. M.; Singh, R.; Wang, Y.; Lefkowitch, J. H.; Rigoli, R. M.; Scherer, P. E.; Czaja, M. J. JNK1 but not JNK2 promotes the development of steatohepatitis in mice Hepatology 2006, 43, 163-72 10.1002/hep.20999
30. Anstee, Q. M.; Goldin, R. D. Mouse models in non-alcoholic fatty liver disease and steatohepatitis research Int. J. Exp. Pathol. 2006, 87, 1-16 10.1111/j.0959-9673.2006.00465.x
31. Ip, E.; Farrell, G. C.; Robertson, G.; Hall, P.; Kirsch, R.; Leclercq, I. Central role of PPARalpha-dependent hepatic lipid turnover in dietary steatohepatitis in mice Hepatology 2003, 38, 123-32 10.1053/jhep.2003.50307
32. Lee, G. S.; Yan, J. S.; Ng, R. K.; Kakar, S.; Maher, J. J. Polyunsaturated fat in the methionine-choline-deficient diet influences hepatic inflammation but not hepatocellular injury J. Lipid Res. 2007, 48, 1885-96 10.1194/jlr.M700181-JLR200
33. George, J.; Pera, N.; Phung, N.; Leclercq, I.; Yun Hou, J.; Farrell, G. Lipid peroxidation, stellate cell activation and hepatic fibrogenesis in a rat model of chronic steatohepatitis J. Hepatol. 2003, 39, 756-64 10.1016/S0168-8278(03)00376-3
34. Phung, N.; Pera, N.; Farrell, G.; Leclercq, I.; Hou, J. Y.; George, J. Pro-oxidant-mediated hepatic fibrosis and effects of antioxidant intervention in murine dietary steatohepatitis Int. J. Mol. Med. 2009, 24, 171-80 10.3892/ijmm-00000220
35. Min, A. K.; Kim, M. K.; Kim, H. S.; Seo, H. Y.; Lee, K. U.; Kim, J. G.; Park, K. G.; Lee, I. K. Alpha-lipoic acid attenuates methionine choline deficient diet-induced steatohepatitis in C57BL/6 mice Life Sci. 2012, 90, 200-5 10.1016/j.lfs.2011.11.012
36. Wree, A.; Broderick, L.; Canbay, A.; Hoffman, H. M.; Feldstein, A. E. From NAFLD to NASH to cirrhosis-new insights into disease mechanisms Nat. Rev. Gastroenterol. Hepatol. 2013, 10, 627-36 10.1038/nrgastro.2013.149
37. Wree, A.; Eguchi, A.; McGeough, M. D.; Pena, C. A.; Johnson, C. D.; Canbay, A.; Hoffman, H. M.; Feldstein, A. E. NLRP3 inflammasome activation results in hepatocyte pyroptosis, liver inflammation, and fibrosis in mice Hepatology 2014, 59, 898-910 10.1002/hep.26592
38. Demiroren, K.; Dogan, Y.; Kocamaz, H.; Ozercan, I. H.; Ilhan, S.; Ustundag, B.; Bahcecioglu, I. H. Protective effects of L-carnitine, N-acetylcysteine and genistein in an experimental model of liver fibrosis Clin. Res. Hepatol. Gastroenterol. 2014, 38, 63-72 10.1016/j.clinre.2013.08.014
39. Salas, A. L.; Montezuma, T. D.; Farina, G. G.; Reyes-Esparza, J.; Rodriguez-Fragoso, L. Genistein modifies liver fibrosis and improves liver function by inducing uPA expression and proteolytic activity in CCl4-treated rats Pharmacology 2008, 81, 41-9 10.1159/000107968
40. Huang, Q.; Huang, R.; Zhang, S.; Lin, J.; Wei, L.; He, M.; Zhuo, L.; Lin, X. Protective effect of genistein isolated from Hydrocotyle sibthorpioides on hepatic injury and fibrosis induced by chronic alcohol in rats Toxicol. Lett. 2013, 217, 102-10 10.1016/j.toxlet.2012.12.014
41. Fukushima, J.; Kamada, Y.; Matsumoto, H.; Yoshida, Y.; Ezaki, H.; Takemura, T.; Saji, Y.; Igura, T.; Tsutsui, S.; Kihara, S.; Funahashi, T.; Shimomura, I.; Tamura, S.; Kiso, S.; Hayashi, N. Adiponectin prevents progression of steatohepatitis in mice by regulating oxidative stress and Kupffer cell phenotype polarization Hepatol. Res. 2009, 39, 724-38 10.1111/j.1872-034X.2009.00509.x
42. Wang, S. N.; Wang, S. T.; Lee, K. T. The potential interplay of adipokines with toll-like receptors in the development of hepatocellular carcinoma Gastroenterol Res. Pract 2011, 2011, 215986 10.1155/2011/215986
43. Finelli, C.; Tarantino, G. What is the role of adiponectin in obesity related non-alcoholic fatty liver disease? World J. Gastroenterol 2013, 19, 802-12 10.3748/wjg.v19.i6.802
44. Witek, R. P.; Stone, W. C.; Karaca, F. G.; Syn, W. K.; Pereira, T. A.; Agboola, K. M.; Omenetti, A.; Jung, Y.; Teaberry, V.; Choi, S. S.; Guy, C. D.; Pollard, J.; Charlton, P.; Diehl, A. M. Pan-caspase inhibitor VX-166 reduces fibrosis in an animal model of nonalcoholic steatohepatitis Hepatology 2009, 50, 1421-30 10.1002/hep.23167
45. Sugino, H.; Kumagai, N.; Watanabe, S.; Toda, K.; Takeuchi, O.; Tsunematsu, S.; Morinaga, S.; Tsuchimoto, K. Polaprezinc attenuates liver fibrosis in a mouse model of non-alcoholic steatohepatitis J. Gastroenterol. Hepatol. 2008, 23, 1909-16 10.1111/j.1440-1746.2008.05393.x
46. Schwimmer, J. B.; Behling, C.; Newbury, R.; Deutsch, R.; Nievergelt, C.; Schork, N. J.; Lavine, J. E. Histopathology of pediatric nonalcoholic fatty liver disease Hepatology 2005, 42, 641-9 10.1002/hep.20842